Azenta (AZTA) Non-Current Deferred Tax Liability (2013 - 2026)
Azenta (AZTA) posted quarterly Non-Current Deferred Tax Liability of $15.7 million for Q1 2026, down 29.43% year-over-year from $22.3 million in Q1 2025, and up 3.27% quarter-over-quarter from $15.2 million in Q4 2025.
Azenta (AZTA) Non-Current Deferred Tax Liability (2013 - 2026) Analysis & Trends
Azenta (AZTA) has reported Non-Current Deferred Tax Liability for 14 consecutive years, with $15.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability fell 29.43% year-over-year to $15.7 million; the TTM figure through Mar 2026 stood at $15.7 million (down 29.43% YoY), while the FY2025 annual figure was $15.2 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability rose to $15.7 million in Q1 2026 per AZTA's latest filing, from $15.2 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $85.9 million in Q4 2022 and bottomed at $2.9 million in Q2 2024.
- Historically, Non-Current Deferred Tax Liability has averaged $39.7 million across 5 years, with a median of $22.3 million in 2025.
- Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability plunged 95.59% — and 2025, when it soared 600.76%.
- Azenta's Non-Current Deferred Tax Liability stood at $85.9 million in 2022, then slipped by 23.31% to $65.9 million in 2023, then sank by 71.2% to $19.0 million in 2024, then dropped by 19.62% to $15.2 million in 2025, then grew by 3.27% to $15.7 million in 2026.
- Business Quant data shows AZTA's Non-Current Deferred Tax Liability at $15.7 million in Q1 2026, $15.2 million in Q4 2025, and $18.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Azenta | 1.69 Bn | 1.37 Bn | 198.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.84 Mn |
| Jun 30, 2026 | 15.84 Mn |
| Mar 31, 2026 | 15.75 Mn |
| Mar 31, 2026 | 15.75 Mn |
| Dec 31, 2025 | 15.25 Mn |
| Dec 31, 2025 | 15.25 Mn |
| Sep 30, 2025 | 18.25 Mn |
| Sep 30, 2025 | 18.25 Mn |
| Jun 30, 2025 | 20.32 Mn |
| Jun 30, 2025 | 20.32 Mn |
| Mar 31, 2025 | 22.31 Mn |
| Mar 31, 2025 | 22.31 Mn |
| Dec 31, 2024 | 18.97 Mn |
| Dec 31, 2024 | 18.97 Mn |
| Sep 30, 2024 | 18.18 Mn |
| Sep 30, 2024 | 18.18 Mn |
| Jun 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 2.90 Mn |
| Mar 31, 2024 | 62.27 Mn |
| Mar 31, 2024 | 62.27 Mn |